Santa Cruz Biotechnology offers a broad range of Fullerene Antibodies for various research applications. Fullerene Antibodies are validated for techniques including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fullerenes, a unique form of carbon, play a significant role in nanotechnology and materials science due to their distinctive structural properties and potential applications in drug delivery and photonics. The interaction of fullerenes with biological systems makes monoclonal Fullerene Antibodies essential tools for studying cellular processes and exploring therapeutic potential. Researchers investigating fullerenes can track their distribution, behavior, and effects within biological systems using specific detection methods. Advanced imaging and analytical techniques combined with Fullerene Antibodies enable precise monitoring of fullerene-based applications in biomedical research. Understanding fullerene interactions at the molecular level supports development of novel therapeutic strategies and materials science innovations. Santa Cruz Biotechnology monoclonal Fullerene Antibodies support researchers worldwide in advancing scientific understanding of these remarkable carbon structures and their potential applications in medicine and technology.